ROCHE was expected to increase its bid for the 44% of GENENTECH it does not own, after the US biotech urged its shareholders to reject a $42bn bid.
LUNDBECK of Denmark is set to expand its presence in the US with theacquisition of specialty firm OVATION.
| |||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||
| 1 2 3 4 5 6 7 8 Next > Last >> | |||||||||||||||||||||||||||||||||||